ArticleBlood advances2023

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.

Raphaelle Aubrais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.